2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$6.41+$0.005 (+0.08%)
Price as of Nov 11, 2026 7:55 PM EST- $242.6MMarket Cap
- -22.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$6.41+$0.005 (+0.08%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.40 | ||
Change | +$0.03 (+0.47%) | ||
Open | $6.37 | ||
High | $6.40 | ||
Low | $6.37 | ||
Previous Close | $6.37 | ||
Volume | 149,718 | ||
30-Day Average Volume | 431,014 | ||
1-Week Change | -0.62% | ||
1-Month Change | -0.78% | ||
1-Year Change | -22.14% | ||
3-Year Change | -8.57% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.9M | ||
Total Assets | $228.3M | ||
Market Cap | $242.6M | ||
Enterprise Value | $231.4M | ||
Period: QTR TTM FY | |||
Revenue | $13.6M | ||
Net Income | -$40.1M | ||
Free Cash Flow | $0.00 | ||
EBIT | -$32.2M | ||
EBITDA | -$29.8M | ||
Net Working Capital | N/A | ||
EPS | -$1.08 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 17 | ||
P/B | -3 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue